Job title: Vice President of Clinical Sciences, Inflammation & Immunology
Dr. Bola Akinlade is Vice President for Regeneron’s Immunology and Inflammation Therapeutic Area. Upon joining Regeneron in 2015, Dr. Akinlade led the immunology and inflammation clinical development team, playing a pivotal role in the approval of Dupixent® (dupilumab) for atopic dermatitis.
Dr. Akinlade is board-certified in Internal Medicine. He received his medical degree from the University of Ibadan and residency training in Internal Medicine at Lagos University Teaching Hospital, both in Nigeria. He completed internal medicine residency at the University of Connecticut, serving also as Chief Resident. He worked as an attending physician for 15 years. He joined Abbott Laboratories in 2003 and Astellas in 2008, where he led drug development teams in anti-infective, immunology, urology and nephrology. Dr. Akinlade is an American College of Physicians fellow and earned his M.B.A. from the Kellogg School of Management, Northwestern University.